Abstract
A region-specific regulation of inflammation on the expression hepcidin in the brain has been demonstrated, however, it remains unknown whether there is also a cell-specific regulation of inflammation on hepcidin in the brain. Here, we investigated the effects of lipopolysaccharides (LPS) on the expression of hepcidin mRNA and also the expression of IL-6 mRNA, the phosphorylation of STAT3 and the expression of ferroportin 1 (Fpn1) and ferritin light chain (Ft-L) proteins in neurons and astrocytes obtained from wild type (IL-6+/+) and IL-6 knockout (IL-6−/−) mice. We demonstrated that the responses of the expression of hepcidin and IL-6 mRNAs, the phosphorylation of STAT3, and the expression of Fpn1 protein to LPS in IL-6+/+ astrocytes and also the responses of the expression of hepcidin mRNA, the phosphorylation of STAT3 and the expression of Fpn1 protein to IL-6 in IL-6−/− astrocytes were much stronger than those in IL-6+/+ and IL-6−/− neurons. A significant increase in Ft-L was found in LPS-treated IL-6+/+ and IL-6-treated IL-6−/− astrocytes, but not in LPS-treated IL-6+/+ and IL-6-treated IL-6−/− neurons. Our findings provide in vitro evidence for the existence of a cell-specific regulation of LPS on the expression of hepcidin and also Ft-L in the brain.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-018-2577-9/MediaObjects/11064_2018_2577_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-018-2577-9/MediaObjects/11064_2018_2577_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-018-2577-9/MediaObjects/11064_2018_2577_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11064-018-2577-9/MediaObjects/11064_2018_2577_Fig4_HTML.gif)
Similar content being viewed by others
Abbreviations
- LPS:
-
Lipopolysaccharides
- Fpn1:
-
Ferroportin 1
- Ft-L:
-
Ferritin light chain
- IL-6−/−:
-
IL-6 knockout
- IL-6:
-
Interleukin-6
- STAT3:
-
Signal transducer and activator of transcription 3
References
Ke Y, Qian ZM (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2:246–253
Ke Y, Qian ZM (2007) Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 83:149–173
Krause A, Neitz S, Magrert HJ, Schulz A, Forssmann WG, Schulz P, Knappe A (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147–150
Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811–7819
Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98:8780–8785
Ganz T (2006) Hepcidin—a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 306:183–198
Zechel S, Huber-Wittmer K, von Bohlen und Halbach O (2006) Distribution of the iron-regulating protein hepcidin in the murine central nervous system. J Neurosci Res 4:790–800
Wang Q, Du F, Qian Z-M, Ge XH, Zhu L, Yung WH, Yang L, Ke Y (2008) Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology 149:3920–3925
Hänninen MM, Haapasalo J, Haapasalo H, Fleming RE, Britton RS, Bacon BR, Parkkila S (2009) Expression of iron-related genes in human brain and brain tumors. BMC Neurosci 10:36
Du F, Qian ZM, Zhu L, Wu XM, Qian C, Chan R, Ke Y (2010) Purity, cell viability, expression of GFAP and bystin in astrocytes cultured by different procedures. J Cell Biochem 109:30–37
Raha-Chowdhury R, Raha AA, Forostyak S, Zhao JW, Stott SR, Bomford A (2015) Expression and cellular localization of hepcidin mRNA and protein in normal rat brain. BMC Neurosci 16:24
Lu LN, Qian ZM, Wu KC, Yung WH, Ke Y (2016) Expression of iron transporters and pathological hallmarks of Parkinson’s and Alzheimer’s diseases in the brain of young, adult, and aged rats. Mol Neurobiol 54:5213–5224
Gong J, Du F, Qian ZM, Luo QQ, Sheng Y, Yung WH, Xu YX, Ke Y (2016) Pre-treatment of rats with ad-hepcidin prevents iron-induced oxidative stress in the brain. Free Radic Biol Med 90:126–132
Wang SM, Fu LJ, Duan XL, Crooks DR, Yu P, Qian ZM, Di XJ, Li J, Rouault TA, Chang YZ (2010) Role of hepcidin in murine brain iron metabolism. Cell Mol Life Sci 67:123–133
Qian ZM, He X, Liang T, Wu KC, Yan YC, Lu LN, Yang G, Luo QQ, Yung WH, Ke Y (2014) Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway. Mol Neurobiol 50:811–820
Xu YX, Du F, Jiang LR, Gong J, Zhou YF, Luo QQ, Qian ZM, Ke Y (2015) Effects of aspirin on expression of iron transport and storage proteins in BV-2 microglial cells. Neurochem Int 91:72–77
Li WY, Li FM, Zhou YF, Wen ZM, Ma J, Ya K, Qian ZM (2016) Aspirin down regulates hepcidin by inhibiting NF-κB and IL6/JAK2/STAT3 pathways in BV-2 microglial cells treated with lipopolysaccharide. Int J Mol Sci 17:E1921
Huang SN, Ruan HZ, Chen MY, Zhou G, Qian ZM (2018) Aspirin increases ferroportin 1 expression by inhibiting hepcidin via the JAK/STAT3 pathway in interleukin 6-treated PC-12 cells. Neurosci Lett 662:1–5
Zhang FL, Hou HM, Yin ZN, Chang L, Li FM, Chen YJ, Ke Y, Qian ZM (2017) Impairment of hepcidin upregulation by lipopolysaccharide in the interleukin-6 knockout mouse brain. Front Mol Neurosci 10:367
Ke Y, Ho K, Du J, Zhu L, Xu Y, Wang Q, Wang CY, Li L, Ge X, Chang Y, Qian ZM (2006) Role of soluble ceruloplasmin in iron uptake by midbrain and hippocampus neurons. J Cell Biochem 98:912–919
Zhao ST, Huang XT, Zhang C, Ke Y (2012) Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase. Neurochem Res 37:153–160
Qian ZM, Liao QK, To Y, Ke Y, Tsoi YK, Wang GF, Ho KP (2000) Transferrin-bound and transferrin free iron uptake by cultured rat astrocytes. Cell Mol Biol 46:541–548
Du F, Zhu L, Qian ZM, Wu XM, Yung WH, Ke Y (2010) Hyperthermic preconditioning protects astrocytes from ischemia/reperfusion injury by up-regulation of HIF-1 alpha expression and binding activity. Biochim Biophys Acta 1802:1048–1053
Chang YZ, Ke Y, Du J, Halpern GM, Ho KP, Zhu L, Gu X, Xu YJ, Wang Q, Li LZ, Wang CY, Qian ZM (2006) Increased divalent metal transporter 1 expression might be associated with the neurotoxicity of L-DOPA. Mol Pharmacol 69:968–974
Huang XT, Qian ZM, He X, Gong Q, Wu KC, Jiang LR, Lu LN, Zhu ZJ, Zhang HY, Yung WH, Ke Y (2014) Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer’s disease. Neurobiol Aging 35:1045–1054
Qian ZM, Chang YZ, Zhu L, Yang L, Du JR, Ho KP, Wang Q, Li LZ, Wang CY, Ge X, **g NL, Li L, Ke Y (2007) Development and iron-dependent expression of hephaestin in different brain regions of rats. J Cell Biochem 102:1225–1233
Qian ZM, Wu XM, Fan M, Yang L, Du F, Yung WH, Ke Y (2011) Divalent metal transporter 1 is a hypoxia-inducible gene. J Cell Physiol 226:1596–1603
Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801
Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV (2009) Toll-like receptors in neurodegeneration. Brain Res Rev 59:278–292
Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA 104:13798–13803
Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275:19906–19912
Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI (2000) Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403:776–781
McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299–309
Ganz T (2013) Systemic iron homeostasis. Physiol Rev 93:1721–1741
Poli M, Asperti M, Ruzzenenti P, Regoni M, Arosio P (2014) Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Front Pharmacol 5:86
Acknowledgements
The studies in our laboratories were supported by National Natural Science Foundation of China (31330035, 31571195), and the National Basic Research Program of China (973) (2014CB541604).
Author information
Authors and Affiliations
Contributions
GZ, YXB and ZMQ conceived, organized and supervised the study; JM, FLZ and YS performed the experiments; YXB and GZ contributed to the analysis of data; ZMQ prepared and wrote the manuscript. All authors read and approved the final edition of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Rights and permissions
About this article
Cite this article
Ma, J., Zhang, FL., Zhou, G. et al. Different Characteristics of Hepcidin Expression in IL-6+/+ and IL-6−/− Neurons and Astrocytes Treated with Lipopolysaccharides. Neurochem Res 43, 1624–1630 (2018). https://doi.org/10.1007/s11064-018-2577-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-018-2577-9